vitiligo disease. Vitiligo
Conditions
Interventions
Intervention 1: intervention group: Participants in the intervention group are treated with Dr Honle Drmalight 3000 phototherapy device with a wavelength of 311 nm 3 times a week for four months. The
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: People with generalized vitiligo who volunteer for NB-UVB phototherapy
Exclusion criteria
Exclusion criteria: Patients with focal or segmental vitiligo Patients with other skin diseases Patients with a history of gastrointestinal ulcers Patients with photosensitivity Patients who have received systemic or topical medication for 2 months Pregnant and lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vitiligo severity score. Timepoint: At the beginning of the study (before the intervention), 2 and 4 months after the start of treatment. Method of measurement: Vitiligo Extent Tensity Index (VETI) score, which its maximum value is 55.5. | — |
Secondary
| Measure | Time frame |
|---|---|
| The patient's tolerance of the treatment. Timepoint: Measurement periods: 2 and 4 months after starting treatment. Method of measurement: At each visit, patients determine their tolerance by choosing one of the following options: 1. Yes 2. No.;The patient's satisfaction with the treatment. Timepoint: Measurement periods: 2 and 4 months after starting treatment. Method of measurement: At each visit, patients determine their level of satisfaction by choosing one of the following options: 1. No 2. A little 3. Moderate 4. Good 5. Excellent. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeideh Farahani
Iran University of Medical Sciences
Outcome results
None listed